Skip to content
lifestyle.childcarepartnerships.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Hemab Therapeutics, Inc.
Hemab Therapeutics Strengthens Board of Directors with Appointment of Keli Walbert
September 24, 2026
Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding
September 17, 2026
Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
June 26, 2026
Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Hemab Therapeutics Reports First Quarter 2026 Financial Results
May 21, 2026
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
April 30, 2026